Roswell Park Researchers Identify Immune Biomarker of Response in Patients With Advanced Liver Cancer

Roswell Park Comprehensive Cancer Center immunology researchers have uncovered a biomarker that may help explain why some patients respond better than others to a common chemotherapy treatment for liver cancer. They hope that their analysis of immune responses among patients receiving sorafenib can lead to more individualized

Read more

Roswell Park Secures More Than $15.4 Million in New Funding for Cancer Research

Roswell Park Comprehensive Cancer Center researchers have received more than a dozen recent grant awards totaling more than $15.4 million. These competitive awards from both government agencies and private funders will fuel research to overcome obstacles in treating diseases like prostate, breast, colon and lung cancer, as

Read more